No evidence of added benefit for most new drugs entering German healthcare system by Staff July 11, 2019 July 11, 2019 83 views 83More than half of new drugs entering the German healthcare system have not been shown to add benefit, argue researchers.Source: sciencedaily.com ScienceDaily 0 FacebookTwitterPinterestEmail previous post New alternate cell growth pathway could lead to better treatments for metastatic cancers next post You Can Now Play Dr. Mario World on Your Mobile Related Posts Siblings with unique genetic change help scientists progress... April 18, 2024 New urine-based test detects high-grade prostate cancer, helping... April 18, 2024 How 3D printers can give robots a soft... April 17, 2024 Honey bees experience multiple health stressors out-in-the-field April 17, 2024 Study identifies new metric for diagnosing autism April 17, 2024 Protecting brain cells with cannabinol April 17, 2024